Euthanasia.

Por Illidge, T. M., Kirkham, S. R.
Publicado em 1992

The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade

Por Dovedi, S J, Illidge, T M
Publicado no Oncoimmunology (2015)

The influence of radiation in the context of developing combination immunotherapies in cancer

Por Honeychurch, Jamie, Illidge, Timothy M.
Publicado no Ther Adv Vaccines Immunother (2018)

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity

Por Honeychurch, Jamie, Dive, Caroline, Illidge, Timothy M.
Publicado em 2013

Radiotherapy–Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery?

Por Romano, Erminia, Honeychurch, Jamie, Illidge, Timothy M.
Publicado no Cancers (Basel) (2021)

Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?

Por Walshaw, Richard C, Honeychurch, Jamie, Illidge, Tim M
Publicado no Br J Radiol (2016)

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations

Por Colton, Madyson, Cheadle, Eleanor J., Honeychurch, Jamie, Illidge, Tim M.
Publicado no Radiat Oncol (2020)

Radiotherapy physics research in the UK: challenges and proposed solutions

Por Mackay, R I, Burnet, N G, Green, S, Illidge, T M, Staffurth, J N
Publicado em 2012

Upregulation of meiosis-specific genes in lymphoma cell lines following genotoxic insult and induction of mitotic catastrophe

Por Kalejs, Martins, Ivanov, Andrey, Plakhins, Gregory, Cragg, Mark S, Emzinsh, Dzintars, Illidge, Timothy M, Erenpreisa, Jekaterina
Publicado em 2006

A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

Por Cheadle, E J, Lipowska-Bhalla, G, Dovedi, S J, Fagnano, E, Klein, C, Honeychurch, J, Illidge, T M
Publicado no Leukemia (2017)

Erratum: A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

Por Cheadle, E J, Lipowska-Bhalla, G, Dovedi, S J, Fagnano, E, Klein, C, Honeychurch, J, Illidge, T M
Publicado no Leukemia (2017)

Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response

Por Melis, M H M, Simpson, K L, Dovedi, S J, Welman, A, MacFarlane, M, Dive, C, Honeychurch, J, Illidge, T M
Publicado em 2013

Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway

Por Honeychurch, Jamie, Alduaij, Waleed, Azizyan, Mahsa, Cheadle, Eleanor J., Pelicano, Helene, Ivanov, Andrei, Huang, Peng, Cragg, Mark S., Illidge, Tim M.
Publicado no Blood (2012)

Antitumor efficacy of radiation plus immunotherapy depends upon dendritic cell activation of effector CDS(+) T cells

Por Dovedi, Simon J., Lipowska-Bhalla, Grazyna, Beers, Stephen A., Cheadle, Eleanor J., Mu, Lijun, Glennie, Martin J., Illidge, Timothy M., Honeychurch, Jamie
Publicado no Cancer Immunol Res (2016)

Akt inhibition improves long‐term tumour control following radiotherapy by altering the microenvironment

Por Searle, Emma J, Telfer, Brian A, Mukherjee, Debayan, Forster, Duncan M, Davies, Barry R, Williams, Kaye J, Stratford, Ian J, Illidge, Tim M
Publicado no EMBO Mol Med (2017)

Endopolyploidy in irradiated p53-deficient tumour cell lines: Persistence of cell division activity in giant cells expressing Aurora B- kinase

Por Erenpreisa, Jekaterina, Ivanov, Andrei, Wheatley, Sally P, Kosmacek, Elizabeth A, Ianzini, Fiorenza, Anisimov, Alim P, Mackey, Michael, Davis, Paul J, Plakhins, Grigorijs, Illidge, Timothy M
Publicado em 2008

Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma

Por Greystoke, A, O'Connor, J P B, Linton, K, Taylor, M B, Cummings, J, Ward, T, Maders, F, Hughes, A, Ranson, M, Illidge, T M, Radford, J, Dive, C
Publicado em 2011

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

Por Alduaij, Waleed, Ivanov, Andrei, Honeychurch, Jamie, Cheadle, Eleanor J., Potluri, Sandeep, Lim, Sean H., Shimada, Kazuyuki, Chan, Claude H. T., Tutt, Alison, Beers, Stephen A., Glennie, Martin J., Cragg, Mark S., Illidge, Tim M.
Publicado em 2011

A novel systemically administered toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models

Por Adlard, Amy L, Dovedi, Simon J, Telfer, Brian A, Koga-Yamakawa, Erina, Pollard, Charlotte, Honeychurch, Jamie, Illidge, Timothy M, Murata, Masashi, Robinson, David T, Jewsbury, Philip J, Wilkinson, Robert W, Stratford, Ian J
Publicado no Int J Cancer (2014)

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

Por Illidge, Tim M., Phillips, Elizabeth H., Counsell, Nicholas, Pettengell, Ruth, Johnson, Peter W. M., Culligan, Dominic J., Popova, Bilyana, Clifton-Hadley, Laura, McMillan, Andrew, Hoskin, Peter, Barrington, Sally F., Radford, John
Publicado no Blood Adv (2020)